R&G PharmaStudies Co Ltd
SZSE:301333
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
42.75
91.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
Price Targets Summary
R&G PharmaStudies Co Ltd
According to Wall Street analysts, the average 1-year price target for R&G PharmaStudies Co Ltd is 67.83 CNY with a low forecast of 67.17 CNY and a high forecast of 69.83 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is R&G PharmaStudies Co Ltd's stock price target?
Price Target
67.83
CNY
According to Wall Street analysts, the average 1-year price target for R&G PharmaStudies Co Ltd is 67.83 CNY with a low forecast of 67.17 CNY and a high forecast of 69.83 CNY.
What is R&G PharmaStudies Co Ltd's Revenue forecast?
Projected CAGR
6%
For the last 4 years the compound annual growth rate for R&G PharmaStudies Co Ltd's revenue is 11%. The projected CAGR for the next 2 years is 6%.
What is R&G PharmaStudies Co Ltd's Operating Income forecast?
Projected CAGR
26%
For the last 4 years the compound annual growth rate for R&G PharmaStudies Co Ltd's operating income is 7%. The projected CAGR for the next 2 years is 26%.
What is R&G PharmaStudies Co Ltd's Net Income forecast?
Projected CAGR
10%
For the last 4 years the compound annual growth rate for R&G PharmaStudies Co Ltd's net income is 14%. The projected CAGR for the next 2 years is 10%.
